SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-013832
Filing Date
2020-05-21
Accepted
2020-05-21 16:06:40
Documents
2
Period of Report
2020-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6343
2 EX-24 DOCUMENT attachment1.htm EX-24 4523
  Complete submission text file 0000899243-20-013832.txt   12301
Mailing Address C/O EXELIXIS INC 170 HARBOR WAY S SAN FRANCISCO CA 94083-0511
Business Address
MCCORMICK FRANK (Reporting) CIK: 0001257809 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 20901912

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences